Korean pharmacy and biopharma companies are considering the unavoidable: the progress to the Chinese market. Rendering to Korea Health Industry Development Institute, Friday, China was the second biggest market for pharmaceuticals after the US in 2018.
The Chinese pharmacy market was set at $142.7 billion, still a far cry from the US at $361.5 billion. Japan struggled in third place at $108 billion and Germany at $71.7 billion. Korea....
Tags : Korea Health Industry Development Institute, China, Celltrion, Samsung Bioepis,
comments (0)